Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Boyer David W. sold 826 Neurocrine Biosciences, Inc. shares (Form 4)
Traded Sep 11 to Sep 14, 2026 · Filed Sep 15, 2026
From Sep 11 to Sep 14, 2026, Boyer David W. (Chief Corp. Affairs Officer) sold 826 Neurocrine Biosciences, Inc. shares at US$157.45 for US$130K under a trading plan, leaving 8,722 shares. Filed Sep 15, 2026 (Form 4).
- Sold
- 826 shares
- Price
- US$157.45
- Value
- US$130K
- Holding after
- 8,722 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Corp. Affairs Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Award | 3,587 | 11,484 | Direct | |
| Sep 11, 2026 | Common Stock | Shares withheld for tax | 1,936 | US$156.22 | 9,548 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 826 | US$157.45 | 8,722 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Boyer David W.
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Boyer David W. · May 28, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026
- Form 4 · Lippoldt Darin · Sep 15, 2026